A 35-year-old woman presents with a 2-year history of recurrent spontaneous bruising, epistaxis, and menorrhagia. Platelet count is 45,000/μL. Bone marrow examination shows adequate megakaryocytes. Which investigation is most appropriate to confirm the suspected diagnosis of immune thrombocytopenia?
A. Bone marrow biopsy with immunohistochemistry
B. Platelet aggregation studies
C. Antiplatelet antibody detection (PAIgG/PAIgM)
D. Flow cytometry for platelet-associated immunoglobulin
Explanation
Diagnostic Approach to Immune Thrombocytopenia (ITP)
Key Point
ITP is a diagnosis of exclusion based on clinical and laboratory findings; antiplatelet antibody detection provides supportive evidence of immune-mediated platelet destruction.
Why Antiplatelet Antibody Detection (PAIgG/PAIgM) is Correct
Antiplatelet antibody assays (PAIgG and PAIgM) detect immunoglobulin bound to platelet surfaces, indicating immune-mediated destruction. While not 100% sensitive or specific, they provide the most direct evidence of autoimmune platelet destruction in the context of:
Thrombocytopenia with adequate bone marrow megakaryocytes
Clinical features of bleeding (bruising, epistaxis, menorrhagia)
Absence of secondary causes
High-YieldNEET PG
PAIgG is more commonly elevated in ITP than PAIgM; combined testing increases sensitivity to ~60–70%.
Diagnostic Criteria for ITP
Table
Finding
Expected in ITP
Platelet count
<150,000/μL
Bone marrow megakaryocytes
Normal or increased
Antiplatelet antibodies (PAIgG/PAIgM)
Positive (60–70%)
Secondary causes
Absent
Splenomegaly
Absent (if present, reconsider diagnosis)
Clinical Pearl
The absence of splenomegaly and the presence of adequate megakaryocytes on bone marrow examination help exclude other causes of thrombocytopenia (e.g., hypersplenism, bone marrow failure, TTP, DIC).
Why Other Investigations Are Secondary
Flow cytometry for platelet-associated immunoglobulin: More sensitive than PAIgG/PAIgM assays but not routinely used for diagnosis; reserved for research or when conventional tests are equivocal.
Bone marrow biopsy with immunohistochemistry: Already performed; confirms adequate megakaryocytes but does not directly assess immune destruction.
Platelet aggregation studies: Used to diagnose platelet function disorders (e.g., Glanzmann thrombasthenia), not immune thrombocytopenia.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
